Our findings add to this growing body of evidence by elaborating a male-specific, mGluR5-dependent neuroadaptation in inhibitory signaling relevant in mouse AD models and identifying female-specific factors that confer resilience to this neuroadaptation. Here, GRM5 is linked to Alzheimer disease.